Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III–IV melanoma: Primary results from RELATIVITY-098.

Georgina V. Long, Hussein A. Tawbi, Jun Guo et al.|Journal of Clinical Oncology|2025

Cited by 7